AI assistant
Cartesian Therapeutics, Inc. — Director's Dealing 2016
Jun 22, 2016
33483_dirs_2016-06-21_54b9596b-7d0f-4d6e-afc7-e6c63410213e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-06-21
Reporting Person: Keller Peter (Chief Business Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5128 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $7.02 | 2026-03-08 | Common Stock (15383) | Direct | |
| Employee Stock Option (right to buy) | $9.36 | 2025-02-20 | Common Stock (10256) | Direct | |
| Employee Stock Option (right to buy) | $8.97 | 2024-04-07 | Common Stock (8461) | Direct | |
| Employee Stock Option (right to buy) | $2.77 | 2023-06-13 | Common Stock (2564) | Direct | |
| Employee Stock Option (right to buy) | $0.63 | 2021-02-16 | Common Stock (94183) | Direct |
Footnotes
F1: Includes 745 shares of restricted common stock which are subject to a right of repurchase by the issuer.
F2: The option vests as to 25% of the shares on February 1, 2017. The remainder of the shares will vest in 36 substantially equal monthly installments thereafter.
F3: The option vested as to 25% of the shares on January 1, 2016. The remainder of the shares vested or will vest in 36 substantially equal monthly installments thereafter.
F4: The option vested as to 25% of the shares on January 1, 2015. The remainder of the shares vested or will vest in 36 substantially equal monthly installments thereafter.
F5: The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested or will vest in 36 substantially equal monthly installments thereafter.
F6: All shares underlying this option are fully vested.